10x Genomics (NASDAQ:TXG) Cut to “Hold” at Leerink Partnrs
Leerink Partnrs downgraded shares of 10x Genomics (NASDAQ:TXG – Free Report) from a strong-buy rating to a hold rating in a report issued on Thursday,Zacks.com reports. Leerink Partnrs also issued estimates for 10x Genomics’ Q1 2026 earnings at ($0.35) EPS. TXG has been the topic of several other research reports. Leerink Partners lowered 10x Genomics […]
Leerink Partnrs downgraded shares of 10x Genomics (NASDAQ:TXG – Free Report) from a strong-buy rating to a hold rating in a report issued on Thursday,Zacks.com reports. Leerink Partnrs also issued estimates for 10x Genomics’ Q1 2026 earnings at ($0.35) EPS. TXG has been the topic of several other research reports. Leerink Partners lowered 10x Genomics […]
